Literature DB >> 15526175

[Acute cor pulmonale in pulmonary embolism. An important prognostic factor and a critical parameter for the choice of a therapeutic strategy].

S Konstantinides1, G Hasenfuss.   

Abstract

Venous thromboembolism remains one of the most frequent and threatening acute cardiovascular syndromes. Its incidence has remained constant over the last several years, both in Europe and the United States, accounting for approximately 1.5 cases per 1000 inhabitants per year. Every year about 100 cases of venous thromboembolism per 100,000 inhabitants are admitted to the hospital, and 10% of these patients die during the hospital stay. Particularly alarming is the fact that in 50-70% of all patients who die from an acute pulmonary embolism the diagnosis is only made after death. These facts emphasize not only the relevance of the problem of "acute pulmonary embolism," but also the need for optimization of current diagnostic and therapeutic strategies. Rapid identification of acute cor pulmonale with echocardiography and cardiac biomarkers has recently proven to be especially helpful in this regard.

Entities:  

Mesh:

Year:  2004        PMID: 15526175     DOI: 10.1007/s00108-004-1267-7

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  37 in total

1.  Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale.

Authors:  E Oger
Journal:  Thromb Haemost       Date:  2000-05       Impact factor: 5.249

Review 2.  Echocardiography in the management of pulmonary embolism.

Authors:  Samuel Z Goldhaber
Journal:  Ann Intern Med       Date:  2002-05-07       Impact factor: 25.391

3.  A noninvasive diagnostic strategy including spiral computed tomography in patients with suspected pulmonary embolism.

Authors:  C Lorut; M Ghossains; M H Horellou; A Achkar; J Fretault; J P Laaban
Journal:  Am J Respir Crit Care Med       Date:  2000-10       Impact factor: 21.405

4.  Right ventricular enlargement on chest computed tomography: prognostic role in acute pulmonary embolism.

Authors:  Rene Quiroz; Nils Kucher; U Joseph Schoepf; Florian Kipfmueller; Scott D Solomon; Philip Costello; Samuel Z Goldhaber
Journal:  Circulation       Date:  2004-05-17       Impact factor: 29.690

5.  The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease.

Authors:  K M McIntyre; A A Sasahara
Journal:  Am J Cardiol       Date:  1971-09       Impact factor: 2.778

Review 6.  Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism, European Society of Cardiology.

Authors: 
Journal:  Eur Heart J       Date:  2000-08       Impact factor: 29.983

7.  Low pro-brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism.

Authors:  Nils Kucher; Gert Printzen; Tanja Doernhoefer; Stephan Windecker; Bernhard Meier; Otto Martin Hess
Journal:  Circulation       Date:  2003-03-24       Impact factor: 29.690

8.  Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism.

Authors:  E Giannitsis; M Müller-Bardorff; V Kurowski; B Weidtmann; U Wiegand; M Kampmann; H A Katus
Journal:  Circulation       Date:  2000-07-11       Impact factor: 29.690

9.  Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology.

Authors:  Albert W Tsai; Mary Cushman; Wayne D Rosamond; Susan R Heckbert; Joseph F Polak; Aaron R Folsom
Journal:  Arch Intern Med       Date:  2002-05-27

Review 10.  Right ventricular dysfunction after acute pulmonary embolism: pathophysiologic factors, detection, and therapeutic implications.

Authors:  J C Lualdi; S Z Goldhaber
Journal:  Am Heart J       Date:  1995-12       Impact factor: 4.749

View more
  1 in total

1.  [A 17-year-old with cardiac mass and pulmonary embolism].

Authors:  W Hein; H Krönert; V Falk; C Wittekind; G Hasenfuss
Journal:  Internist (Berl)       Date:  2009-12       Impact factor: 0.743

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.